State Street’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $398K | Hold |
120,500
| – | – | ﹤0.01% | 3665 |
|
|
2025
Q1 | $345K | Hold |
120,500
| – | – | ﹤0.01% | 3689 |
|
|
2024
Q4 | $280K | Buy |
120,500
+8,600
| +8% | +$20K | ﹤0.01% | 3774 |
|
|
2024
Q3 | $352K | Hold |
111,900
| – | – | ﹤0.01% | 3665 |
|
|
2024
Q2 | $247K | Buy |
111,900
+3,400
| +3% | +$7.51K | ﹤0.01% | 3759 |
|
|
2024
Q1 | $339K | Hold |
108,500
| – | – | ﹤0.01% | 3746 |
|
|
2023
Q4 | $421K | Buy |
108,500
+6,400
| +6% | +$24.8K | ﹤0.01% | 3685 |
|
|
2023
Q3 | $334K | Hold |
102,100
| – | – | ﹤0.01% | 3778 |
|
|
2023
Q2 | $327K | Hold |
102,100
| – | – | ﹤0.01% | 3838 |
|
|
2023
Q1 | $439K | Hold |
102,100
| – | – | ﹤0.01% | 3786 |
|
|
2022
Q4 | $434K | Hold |
102,100
| – | – | ﹤0.01% | 3818 |
|
|
2022
Q3 | $502K | Hold |
102,100
| – | – | ﹤0.01% | 3776 |
|
|
2022
Q2 | $312K | Hold |
102,100
| – | – | ﹤0.01% | 4013 |
|
|
2022
Q1 | $280K | Buy |
102,100
+11,213
| +12% | +$30.8K | ﹤0.01% | 4263 |
|
|
2021
Q4 | $270K | Hold |
90,887
| – | – | ﹤0.01% | 4218 |
|
|
2021
Q3 | $434K | Buy |
90,887
+67,600
| +290% | +$323K | ﹤0.01% | 4033 |
|
|
2021
Q2 | $90K | Buy |
+23,287
| New | +$90K | ﹤0.01% | 4379 |
|